579 related articles for article (PubMed ID: 19727074)
41. Mutations of the BRAF gene in human cancer.
Davies H; Bignell GR; Cox C; Stephens P; Edkins S; Clegg S; Teague J; Woffendin H; Garnett MJ; Bottomley W; Davis N; Dicks E; Ewing R; Floyd Y; Gray K; Hall S; Hawes R; Hughes J; Kosmidou V; Menzies A; Mould C; Parker A; Stevens C; Watt S; Hooper S; Wilson R; Jayatilake H; Gusterson BA; Cooper C; Shipley J; Hargrave D; Pritchard-Jones K; Maitland N; Chenevix-Trench G; Riggins GJ; Bigner DD; Palmieri G; Cossu A; Flanagan A; Nicholson A; Ho JW; Leung SY; Yuen ST; Weber BL; Seigler HF; Darrow TL; Paterson H; Marais R; Marshall CJ; Wooster R; Stratton MR; Futreal PA
Nature; 2002 Jun; 417(6892):949-54. PubMed ID: 12068308
[TBL] [Abstract][Full Text] [Related]
42. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
[TBL] [Abstract][Full Text] [Related]
43. Protein Kinase A-independent Ras Protein Activation Cooperates with Rap1 Protein to Mediate Activation of the Extracellular Signal-regulated Kinases (ERK) by cAMP.
Li Y; Dillon TJ; Takahashi M; Earley KT; Stork PJ
J Biol Chem; 2016 Oct; 291(41):21584-21595. PubMed ID: 27531745
[TBL] [Abstract][Full Text] [Related]
44. Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma.
Zhou B; Ritt DA; Morrison DK; Der CJ; Cox AD
J Biol Chem; 2016 Aug; 291(34):17804-15. PubMed ID: 27226552
[TBL] [Abstract][Full Text] [Related]
45. C. elegans SUR-6/PR55 cooperates with LET-92/protein phosphatase 2A and promotes Raf activity independently of inhibitory Akt phosphorylation sites.
Kao G; Tuck S; Baillie D; Sundaram MV
Development; 2004 Feb; 131(4):755-65. PubMed ID: 14724126
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association.
Yip-Schneider MT; Miao W; Lin A; Barnard DS; Tzivion G; Marshall MS
Biochem J; 2000 Oct; 351(Pt 1):151-9. PubMed ID: 10998357
[TBL] [Abstract][Full Text] [Related]
47. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
Park JI; Strock CJ; Ball DW; Nelkin BD
Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
[TBL] [Abstract][Full Text] [Related]
48. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade.
Avruch J; Khokhlatchev A; Kyriakis JM; Luo Z; Tzivion G; Vavvas D; Zhang XF
Recent Prog Horm Res; 2001; 56():127-55. PubMed ID: 11237210
[TBL] [Abstract][Full Text] [Related]
49. Critical contribution of linker proteins to Raf kinase activation.
Anselmo AN; Bumeister R; Thomas JM; White MA
J Biol Chem; 2002 Feb; 277(8):5940-3. PubMed ID: 11741918
[TBL] [Abstract][Full Text] [Related]
50. Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding.
Zhu J; Balan V; Bronisz A; Balan K; Sun H; Leicht DT; Luo Z; Qin J; Avruch J; Tzivion G
Mol Biol Cell; 2005 Oct; 16(10):4733-44. PubMed ID: 16093354
[TBL] [Abstract][Full Text] [Related]
51. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
Karreth FA; DeNicola GM; Winter SP; Tuveson DA
Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
[TBL] [Abstract][Full Text] [Related]
52. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
53. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.
Vakana E; Pratt S; Blosser W; Dowless M; Simpson N; Yuan XJ; Jaken S; Manro J; Stephens J; Zhang Y; Huber L; Peng SB; Stancato LF
Oncotarget; 2017 Feb; 8(6):9251-9266. PubMed ID: 27999210
[TBL] [Abstract][Full Text] [Related]
54. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
55. Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein.
Takahashi-Niki K; Kato-Ose I; Murata H; Maita H; Iguchi-Ariga SMM; Ariga H
J Biol Chem; 2015 Jul; 290(29):17838-17847. PubMed ID: 26048984
[TBL] [Abstract][Full Text] [Related]
56. Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP.
Takahashi M; Li Y; Dillon TJ; Stork PJ
J Biol Chem; 2017 Jan; 292(4):1449-1461. PubMed ID: 28003362
[TBL] [Abstract][Full Text] [Related]
57. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
58. Regulation of the Raf kinase by phosphorylation.
Zhang BH; Guan KL
Exp Lung Res; 2001; 27(3):269-95. PubMed ID: 11293329
[TBL] [Abstract][Full Text] [Related]
59. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
[TBL] [Abstract][Full Text] [Related]
60. RAF kinase dimerization: implications for drug discovery and clinical outcomes.
Brummer T; McInnes C
Oncogene; 2020 May; 39(21):4155-4169. PubMed ID: 32269299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
